期刊文献+

表浅性膀胱移行细胞癌预后因素分析

Analysis of the Prognostic Factors in Patients with Superficial Transitional Cell Carcinoma of Bladder
暂未订购
导出
摘要 目的探讨与表浅性膀胱移行细胞癌复发、进展、生存相关的显著性因素。方法应用Cox风险比例模型和Kaplan-Meier法及Log-rank检验方法对153例表浅性膀胱移行细胞癌的13项指标与复发、进展及生存时间进行统计分析。结果发现与复发相关的因素为肿瘤的大小、组织学分级及膀胱灌注情况。影响进展的主要因素为肿瘤的形态、组织学分级、膀胱灌注情况及症状的持续时间。影响肿瘤特异生存率的变量为肿瘤的形态、组织学分级及症状的持续时间。结论对随访资料进行生存分析,组织学分级是影响预后的主要因素,膀胱灌注治疗是重要的保护性因素。 Objective To evaluate the prognosth, factors affecting recurrence,progression and cancer-specific survival in patients with prilnary superficial transitional cell carcinoma of bladder. Methods Using Kaplan-Meier method, Log-rank test and Cox proportional hazards model, the retrospective survival analysis was performed in 153 patients with superficial transitional cell carcinoma of bladder. Results The main variables affecting recurrence were tumor size, histological grades and intravesical chemotherapeutic instillations. The main variables affecting progression were tumor shape, histological grades,the duration of symptoms and intravesical chemotherapeutie instillations. The variables that could predict cancer specific survival were tumor shape, histological grades and the duration of symptoms. Conclusions By cancer-specific survival analysis of the follow-up data,we can identity the main prognostic factors was histological grades,intravcsical chemotherapeutic instillations was the protective tacter.
出处 《潍坊医学院学报》 2008年第1期79-81,共3页 Acta Academiae Medicinae Weifang
关键词 膀胱肿瘤 预后 移行细胞 Bladder tumor Prognosis Transitional cell
  • 相关文献

参考文献9

  • 1Kurth KH.Intravesical chemotherapy for superficial bladder tumors calegray Ta/T1:Who should be treated and how[J].Sem InUrol Oncol,1996,14:30-35.
  • 2Rodrignez FM,Toniolo GC,Bayarri JS,et al.Multivaritc analysis of the prognostic factors of primary superficial bladder cancer[J].J Urol,2000,163 (1):73-78.
  • 3Richard J,Sylvoster R J,Adrian PM.Predicting recurrence and progression in individual patients with stage Ta/T1 bladder cancer using EORTC risk tables:a combined analysis of 2596 patients from seven EORTC trials[J].J Eur Urol,2006,49:466-477.
  • 4Kiemeney LALM,Witjes JA,Heijbreek RP,et al.Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer[J].J Urol,1993,150:60-64.
  • 5Millan-Rodrignez F,Chechile-Toniolo G,Salvador-Bayarri J,et al.Multivariate analysis of the prognostic factors of primary superficial bladder cancer[J].J Urol,2000,163:73-78.
  • 6魏强,唐孝达,杨宇如,李虹,张卫东,陈宗福.影响膀胱肿瘤术后复发的 COX 回归模型多因素分析[J].中华泌尿外科杂志,1997,18(3):162-165. 被引量:17
  • 7Sylvester RJ,Oosterlinck W,Van der Meijden AP.A single immediate postoperative instillation of chemotherapy dereases the risk of recurrence in patients with stage Ta/T1 bladder cancer:a meta-analysis of published results of randomized clinical trials[J].J Urol,2004,171(6Pt1):2186-2190.
  • 8Koga H,Kuroiwa K,Yamaguchi A,et al.A randomized controlled trial of short-term versus long-term prophylactic intravesical insillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder[J].J Urol,2004,171(1):153-157.
  • 9Rodrignez-Aloson A,Pits-femandez S,Gonzalez-Carrere J,et al.Multi-variate analysis of survival,recurrence,progression and development of metastasis in T1 and T2 transitional cell bladder carcinoma[J].Cancer,2002,94:1677-1684.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部